Breaking: AstraZeneca set to strike drug pricing deal with Trump

It will be the second pharma company to pledge lower prices amid increasing pressure from the administration.

Log In    Subscribe BREAKING NEWS   AstraZeneca set to strike drug pricing deal with Trump By Daniel Payne HECTOR RETAMAL/AFP via Getty Images AstraZeneca is set to strike a deal with the Trump administration to lower drug prices, people familiar with the matter told STAT.   More details of the deal are set to be shared at a 5 p.m. announcement with President Trump in the Oval Office. The expected action comes just weeks after Pfizer was the first pharma company to pledge to lower prices in line with what it charges in other countries, setting off a scramble across the sector to ink a deal with the White House. READ MORE Sign up for the Readout Your morning rundown of the science, politics, and money driving biotech today. Learn more. In Case You Missed It 1   Pharma companies scramble to make deals with Trump after Pfizer scored White House praise By Daniel Payne 2   Will the White House drug-pricing deal lower costs for Americans? Experts are skeptical By Elaine Chen 3   Senate-passed BIOSECURE Act would add arrow to Trump's drug-pricing quiver By John Wilkerson 4   Court ruling allows Medicare to negotiate prices for larger number of drugs By John Wilkerson Don't miss out on another STAT investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us